Browse > Article
http://dx.doi.org/10.5483/BMBRep.2019.52.7.231

Protective effects of N,4,5-trimethylthiazol-2-amine hydrochloride on hypoxia-induced β-amyloid production in SH-SY5Y cells  

Han, A Reum (Department of Biochemistry and Molecular Biology, University of Ulsan College of Medicine)
Yang, Ji Woong (Department of Biochemistry and Molecular Biology, University of Ulsan College of Medicine)
Na, Jung-Min (Department of Biochemistry and Molecular Biology, University of Ulsan College of Medicine)
Choi, Soo Young (Department of Biomedical Science and Research Institute of Bioscience and Biotechnology, Hallym University)
Cho, Sung-Woo (Department of Biochemistry and Molecular Biology, University of Ulsan College of Medicine)
Publication Information
BMB Reports / v.52, no.7, 2019 , pp. 439-444 More about this Journal
Abstract
Although hypoxic/ischemic injury is thought to contribute to the incidence of Alzheimer's disease (AD), the molecular mechanism that determines the relationship between hypoxia-induced ${\beta}$-amyloid ($A{\beta}$) generation and development of AD is not yet known. We have now investigated the protective effects of N,4,5-trimethylthiazol-2-amine hydrochloride (KHG26702), a novel thiazole derivative, on oxygen-glucose deprivation (OGD)-reoxygenation (OGD-R)-induced $A{\beta}$ production in SH-SY5Y human neuroblastoma cells. Pretreatment of these cells with KHG26702 significantly attenuated OGD-R-induced production of reactive oxygen species and elevation of levels of malondialdehyde, prostaglandin $E_2$, interleukin 6 and glutathione, as well as superoxide dismutase activity. KHG26702 also reduced OGD-R-induced expression of the apoptotic protein caspase-3, the apoptosis regulator Bcl-2, and the autophagy protein becn-1. Finally, KHG26702 reduced OGD-R-induced $A{\beta}$ production and cleavage of amyloid precursor protein, by inhibiting secretase activity and suppressing the autophagic pathway. Although supporting data from in vivo studies are required, our results indicate that KHG26702 may prevent neuronal cell damage from OGD-R-induced toxicity.
Keywords
Amyloid protein; Hypoxia; Ischemia; N,4,5-trimethylthiazol-2-amine hydrochloride;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Taveira M, Sousa C, Valentao P et al (2014) Neuroprotective effect of steroid alalkaloids on glutamateinduced toxicity by preserving mitochondrial membrane potential and reducing oxidative stress. J Steroid Biochem Mol Biol 140, 106-115   DOI
2 Nalivaevaa NN, Fisk L, Kochkina EG et al (2004) Effect of hypoxia/ischemia and hypoxic preconditioning/reperfusion on expression of some amyloid-degrading enzymes. Ann New York Aca Sci 1035, 21-33   DOI
3 Pluta R, Furmaga-Jablonska W, Maciejewski R et al (2013) Brain ischemia activates ${\beta}$- and $\gamma$-secretase cleavage of amyloid precursor protein: significance in sporadic Alzheimer's disease. Mol Neurobiol 47, 425-434   DOI
4 Shiota S, Takekawa H, Matsumoto SE et al (2013) Chronic intermittent hypoxia/reoxygenation facilitate amyloid-${\beta}$ generation in mice. J Alzheimers Dis 37, 325-333   DOI
5 Gould E (2007) How widespread is adult neurogenesis in mammals? Nat Rev Neurosci 8, 481-488   DOI
6 Li L, Zhang X, Yang D et al (2009) Hypoxia increases $A{\beta}$ generation by altering ${\beta}$- and $\gamma$-cleavage of APP. Neurobiol Aging 30, 1091-1098   DOI
7 Li Q, Wang HM, Wang ZQ et al (2010) Salidroside attenuates hypoxia-induced abnormal processing of amyloid precursor protein by decreasing BACE1 expression in SH-SY5Y cells. Neurosci Lett 481, 154-158   DOI
8 Margaill I, Plotkine M and Lerouet D (2005) Antioxidant strategies in the treatment of stroke. Free Radic Biol Med 39, 429-443   DOI
9 Carboni S, Hiver A, Szyndralewiez C et al (2004) AS601245 (1,3-benzothiazol-2-yl (2-[[2-(3-pyridinyl) ethyl] amino]-4 pyrimidinyl) acetonitrile): a c-Jun NH2-terminal protein kinase inhibitor with neuroprotective properties. J Pharmacol Exp Ther 310, 25-32   DOI
10 Salminen A, Kauppinen A and Kaarniranta K (2017) Hypoxia/ischemia activate processing of Amyloid precursor protein: impact of vascular dysfunction in the pathogenesis of Alzheimer's disease. J Neurochem 140, 536-549   DOI
11 Choi MM, Kim EA, Hahn HG et al (2007) Protective effect of benzothiazole derivative KHG21834 on amyloid beta-induced neurotoxicity in PC12 cells and cortical and mesencephalic neurons. Toxicology 239, 156-166   DOI
12 Miglio G, Varsaldi F, Francioli E et al (2004) Cabergoline protects SH-SY5Y neuronal cells in an in vitro model of ischemia. Eur J Pharmacol 489, 157-165   DOI
13 Kunwar A, Sandur SK, Krishna M et al (2009) Curcumin mediates time and concentration dependent regulation of redox homeostasis leading to cytotoxicity in macrophage cells. Eur J Pharmacol 611, 8-16   DOI
14 Fallarini S, Miglio G, Paoletti T et al (2009) Clovamide and rosmarinic acid induce neuroprotective effects in in vitro models of neuronal death. Br J Pharmacol 157, 1072-1084   DOI
15 Lewen A, Matz P and Chan PH (2000) Free radical pathways in CNS injury. J Neurotrauma 17, 871-890   DOI
16 Urabe T, Yamasaki Y, Hattori N et al (2000) Accumulation of 4-hydroxynonenal-modified proteins in hippocampal CA1 pyramidal neurons precedes delayed neuronal damage in the gerbil brain. Neuroscience 100, 241-250   DOI
17 Katoh S, Mitsui Y, Kitani K et al (1999) Hyperoxia induces the neuronal differentiated phenotype of PC12 cells via a sustained activity of mitogen-activated protein kinase induced by Bcl-2. Biochem J 338, 465-470   DOI
18 Conrad M and Sato H (2012) The oxidative stressinducible cystine/glutamate antiporter, system x (c) (-): cystine supplier and beyond. Amino Acids 42, 231-246   DOI
19 Le DA, Wu Y, Huang Z et al (2002) Caspase activation and neuroprotection in caspase-3-deficient mice after in vivo cerebral ischemia and in vitro oxygen glucose deprivation. Proc Natl Acad Sci U S A 99, 15188-15193   DOI
20 Niwa M, Hara A, Iwai T, et al (2001) Caspase activation as an apoptotic evidence in the gerbil hippocampal CA1 pyramidal cells following transient forebrain ischemia. Neurosci Lett 300, 103-106   DOI
21 Wang Q, Sun AY, Simonyi A et al (2005) Neuroprotective mechanisms of curcumin against cerebral ischemiainduced neuronal apoptosis and behavioral deficits. J Neurosci Res 82, 138-148   DOI
22 Suzuki WA and Amaral DG (2004) Functional neuroanatomy of the medial temporal lobe memory system. Cortex 40, 220-222   DOI
23 Zhao H, Yenari MA, Cheng D et al (2003) Bcl-2 overexpression protects against neuron loss within the ischemic margin following experimental stroke and inhibits cytochrome c translocation and caspase-3 activity. J Neurochem 85, 1026-1036   DOI
24 Karch J and Molkentin JD (2015) Regulated necrotic cell death: the passive aggressive side of Bax and Bak. Circ Res 116, 1800-1809   DOI
25 Braak H, Braak E and Bohl J (1993) Staging of Alzheimerrelated cortical destruction. Eur Neurol 33, 403-408   DOI
26 Banati RB, Gehrmann J, Wiessner C et al (1995) Glial expression of the beta-amyloid precursor protein (APP) in global ischemia. J Cereb Blood Flow Metab 15, 647-654   DOI
27 Webster NJ, Green KN, Peers C et al (2002) Altered processing of amyloid precursor protein in the human neuroblastoma SH-SY5Y by chronic hypoxia. J Neurochem 83, 1262-1271   DOI
28 Mattson MP (2004) Pathways towards and away from Alzheimer's disease. Nature 430, 631-639   DOI
29 Muller UC, Deller T and Korte M (2017) Not just amyloid: physiological functions of the amyloid precursor protein family. Nat Rev Neurosci 18, 281-298   DOI
30 Yu WH, Cuervo AM, Kumar A et al (2005) Macroautophagy- a novel Beta-amyloid peptide generating pathway activated in Alzheimer's disease. J Cell Biol 171, 87-98   DOI